| |
Prevalence
|
Concordance
|
|---|
| |
Clinician-collected
|
Self-collected
| |
% Positive agreement
| | |
|---|
| |
Prevalence
|
95% CI
|
Prevalence
|
95% CI
|
% Agreement
|
Kappa
|
p
|
|---|
|
Any HPV
|
42.4%
|
37.5%-47.3%
|
54.7%
|
49.7%-59.6%
|
73%
|
57%
|
0.48
|
<0.001
|
|
Carcinogenic
|
18.0%
|
14.4%-22.1%
|
26.8%
|
22.6%-31.4%
|
84%
|
47%
|
0.54
|
<0.001
|
|
Non-Carcinogenic
|
31.8%
|
27.3%-36.5%
|
44.6%
|
39.7%-49.6%
|
75%
|
53%
|
0.49
|
<0.001
|
|
alpha 1/8/10
|
3.2%
|
1.7%-5.4%
|
5.2%
|
3.2%-7.8%
|
97%
|
42%
|
0.57
|
0.06
|
|
alpha 5/6/9/11
|
28.8%
|
24.5%-33.%
|
41.4%
|
36.5%-46.4%
|
77%
|
51%
|
0.51
|
<0.001
|
|
alpha 3/4/15
|
21.2%
|
17.3%-25.5%
|
31.8%
|
27.3%-36.5%
|
82%
|
48%
|
0.53
|
<0.001
|
- Differences in prevalence detected in clinician- and self-collected specimens were tested for statistical differences using an exact version of McNemar’s chi-square test. P value of less than 0.05 is considered significant and indicated by bolded font.
